Welcome to Novo Nordisk in the United States

Research & Development

About Seattle, WA

In 2009, Novo Nordisk established the research center in Seattle to advance its research pipeline. The unique concept behind the center is to combine basic research, early proof-of-concept trials, and medical device research under one umbrella. Researchers at the center have a mandate to pursue a translational research approach to finding new antigen-based immunological and vaccine treatment advances for type 1 diabetes and obesity, and to identify game changing devices to support treatments.

Click here to see  current open positions at our Seattle, WA facility.